Drug Type Stem cell therapy |
Synonyms Implanted autologous skeletal myoblasts U.S. Stem Cell, MyoCell II, Myoblastderived autologous stem cell therapy U.S. Stem Cell + [1] |
Target- |
Action- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date South Korea (06 Jul 2016), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Heart Failure | South Korea | 06 Jul 2016 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Failure | Discovery | United States | 01 Sep 2007 | |
Myocardial Infarction | Discovery | United States | 01 Sep 2007 | |
Coronary Artery Disease | Discovery | United States | 01 Feb 2003 |